메뉴 건너뛰기




Volumn 6, Issue 8, 2013, Pages 764-773

The invisible arm of immunity in common cancer chemoprevention agents

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AROMATASE INHIBITOR; BISPHOSPHONIC ACID DERIVATIVE; CANCER ANTIBODY; CANCER VACCINE; CYCLOOXYGENASE 2 INHIBITOR; IMMUNOMODULATING AGENT;

EID: 84883748345     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-13-0036     Document Type: Review
Times cited : (37)

References (96)
  • 1
    • 0030965103 scopus 로고    scopus 로고
    • Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children
    • Taiwan Childhood Hepatoma Study Group
    • Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997;336:1855-9.
    • (1997) N Engl J Med , vol.336 , pp. 1855-1859
    • Chang, M.H.1    Chen, C.J.2    Lai, M.S.3    Hsu, H.M.4    Wu, T.C.5    Kong, M.S.6
  • 2
    • 77955099933 scopus 로고    scopus 로고
    • Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: Randomised controlled trial
    • Group FIIS
    • Group FIIS, Dillner J, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE, et al. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ 2010;341:c3493.
    • (2010) BMJ , vol.341
    • Dillner, J.1    Kjaer, S.K.2    Wheeler, C.M.3    Sigurdsson, K.4    Iversen, O.E.5
  • 3
    • 0037341533 scopus 로고    scopus 로고
    • Observing the invisible: Successful tumor immunity in humans
    • DOI 10.1038/ni0303-201
    • Darnell RB, Posner JB. Observing the invisible: successful tumor immunity in humans. Nat Immunol 2003;4:201. (Pubitemid 36322123)
    • (2003) Nature Immunology , vol.4 , Issue.3 , pp. 201
    • Darnell, R.B.1    Posner, J.B.2
  • 5
    • 84858800620 scopus 로고    scopus 로고
    • The immune contexture in human tumours: Impact on clinical outcome
    • Fridman WH, Pages F, Sautes-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 2012;12:298-306.
    • (2012) Nat Rev Cancer , vol.12 , pp. 298-306
    • Fridman, W.H.1    Pages, F.2    Sautes-Fridman, C.3    Galon, J.4
  • 6
    • 79952093380 scopus 로고    scopus 로고
    • Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction
    • Mlecnik B, Tosolini M, Kirilovsky A, Berger A, Bindea G, Meatchi T, et al. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol 2011;29:610-8.
    • (2011) J Clin Oncol , vol.29 , pp. 610-618
    • Mlecnik, B.1    Tosolini, M.2    Kirilovsky, A.3    Berger, A.4    Bindea, G.5    Meatchi, T.6
  • 9
    • 78149432308 scopus 로고    scopus 로고
    • Immune regulation of cancer
    • Disis ML. Immune regulation of cancer. J Clin Oncol 2010;28:4531-8.
    • (2010) J Clin Oncol , vol.28 , pp. 4531-4538
    • Disis, M.L.1
  • 11
    • 65349152488 scopus 로고    scopus 로고
    • Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: An international consensus statement
    • Cuzick J, Otto F, Baron JA, Brown PH, Burn J, Greenwald P, et al. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol 2009;10:501-7.
    • (2009) Lancet Oncol , vol.10 , pp. 501-507
    • Cuzick, J.1    Otto, F.2    Baron, J.A.3    Brown, P.H.4    Burn, J.5    Greenwald, P.6
  • 12
    • 33947541519 scopus 로고    scopus 로고
    • Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement
    • Force USPST
    • Force USPST. Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2007;146:361-4.
    • (2007) Ann Intern Med , vol.146 , pp. 361-364
  • 15
    • 84861529382 scopus 로고    scopus 로고
    • Low-dose aspirin and cancer mortality: A meta-analysis of randomized trials
    • Mills EJ, Wu P, Alberton M, Kanters S, Lanas A, Lester R. Low-dose aspirin and cancer mortality: a meta-analysis of randomized trials. Am J Med 2012;125:560-7.
    • (2012) Am J Med , vol.125 , pp. 560-567
    • Mills, E.J.1    Wu, P.2    Alberton, M.3    Kanters, S.4    Lanas, A.5    Lester, R.6
  • 16
    • 78650825618 scopus 로고    scopus 로고
    • Effect of daily aspirin on long-term risk of death due to cancer: Analysis of individual patient data from randomised trials
    • Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 2011;377:31-41.
    • (2011) Lancet , vol.377 , pp. 31-41
    • Rothwell, P.M.1    Fowkes, F.G.2    Belch, J.F.3    Ogawa, H.4    Warlow, C.P.5    Meade, T.W.6
  • 17
    • 84863412124 scopus 로고    scopus 로고
    • Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: Analysis of the time course of risks and benefits in 51 randomised controlled trials
    • Rothwell PM, Price JF, Fowkes FG, Zanchetti A, Roncaglioni MC, Tognoni G, et al. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet 2012;379:1602-12.
    • (2012) Lancet , vol.379 , pp. 1602-1612
    • Rothwell, P.M.1    Price, J.F.2    Fowkes, F.G.3    Zanchetti, A.4    Roncaglioni, M.C.5    Tognoni, G.6
  • 18
    • 0027993458 scopus 로고
    • Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
    • Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994;107:1183-8. (Pubitemid 24294584)
    • (1994) Gastroenterology , vol.107 , Issue.4 , pp. 1183-1188
    • Eberhart, C.E.1    Coffey, R.J.2    Radhika, A.3    Giardiello, F.M.4    Ferrenbach, S.5    DuBois, R.N.6
  • 19
    • 0037086261 scopus 로고    scopus 로고
    • Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ
    • Half E, Tang XM, Gwyn K, Sahin A, Wathen K, Sinicrope FA. Cyclo-oxygenase- 2 expression in human breast cancers and adjacent ductal carcinoma in situ. Cancer Res 2002;62:1676-81. (Pubitemid 34408488)
    • (2002) Cancer Research , vol.62 , Issue.6 , pp. 1676-1681
    • Half, E.1    Tang, X.M.2    Gwyn, K.3    Sahin, A.4    Wathen, K.5    Sinicrope, F.A.6
  • 20
    • 59449100165 scopus 로고    scopus 로고
    • High expression of PGE2 enzymatic pathways in cervical (pre)neoplastic lesions and functional consequences for antigen-presenting cells
    • Herfs M, Herman L, Hubert P, Minner F, Arafa M, Roncarati P, et al. High expression of PGE2 enzymatic pathways in cervical (pre)neoplastic lesions and functional consequences for antigen-presenting cells. Cancer Immunol Immunother 2009;58:603-14.
    • (2009) Cancer Immunol Immunother , vol.58 , pp. 603-614
    • Herfs, M.1    Herman, L.2    Hubert, P.3    Minner, F.4    Arafa, M.5    Roncarati, P.6
  • 22
    • 84857141464 scopus 로고    scopus 로고
    • Neoplastic "Black Ops": Cancer's subversive tactics in overcoming host defenses
    • Biragyn A, Longo DL. Neoplastic "Black Ops": cancer's subversive tactics in overcoming host defenses. Semin Cancer Biol 2012;22:50-9.
    • (2012) Semin Cancer Biol , vol.22 , pp. 50-59
    • Biragyn, A.1    Longo, D.L.2
  • 25
    • 84864072013 scopus 로고    scopus 로고
    • Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis
    • Bhalla K, Hwang BJ, Dewi RE, Twaddel W, Goloubeva OG, Wong KK, et al. Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis. Cancer Prev Res 2012;5:544-52.
    • (2012) Cancer Prev Res , vol.5 , pp. 544-552
    • Bhalla, K.1    Hwang, B.J.2    Dewi, R.E.3    Twaddel, W.4    Goloubeva, O.G.5    Wong, K.K.6
  • 28
    • 77956411030 scopus 로고    scopus 로고
    • Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial
    • Hosono K, Endo H, Takahashi H, Sugiyama M, Sakai E, Uchiyama T, et al. Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial. Cancer Prev Res 2010;3:1077-83.
    • (2010) Cancer Prev Res , vol.3 , pp. 1077-1083
    • Hosono, K.1    Endo, H.2    Takahashi, H.3    Sugiyama, M.4    Sakai, E.5    Uchiyama, T.6
  • 30
    • 33751536158 scopus 로고    scopus 로고
    • Immune selective pressure and HLA class I antigen defects in malignant lesions
    • DOI 10.1007/s00262-006-0183-1
    • Chang CC, Ferrone S. Immune selective pressure and HLA class I antigen defects in malignant lesions. Cancer Immunol Immunother 2007;56:227-36. (Pubitemid 44833096)
    • (2007) Cancer Immunology, Immunotherapy , vol.56 , Issue.2 , pp. 227-236
    • Chang, C.-C.1    Ferrone, S.2
  • 32
    • 79953125101 scopus 로고    scopus 로고
    • Strategies to counteract MHC-I defects in tumors
    • Lampen MH, van Hall T. Strategies to counteract MHC-I defects in tumors. Curr Opin Immunol 2011;23:293-8.
    • (2011) Curr Opin Immunol , vol.23 , pp. 293-298
    • Lampen, M.H.1    Van Hall, T.2
  • 33
    • 78649829433 scopus 로고    scopus 로고
    • Oxidative phosphorylation induces de novo expression of the MHC class I in tumor cells through the ERK5 pathway
    • Charni S, de Bettignies G, Rathore MG, Aguilo JI, van den Elsen PJ, Haouzi D, et al. Oxidative phosphorylation induces de novo expression of the MHC class I in tumor cells through the ERK5 pathway. J Immunol 2010;185:3498-503.
    • (2010) J Immunol , vol.185 , pp. 3498-3503
    • Charni, S.1    De Bettignies, G.2    Rathore, M.G.3    Aguilo, J.I.4    Van Den Elsen, P.J.5    Haouzi, D.6
  • 34
    • 84857969223 scopus 로고    scopus 로고
    • Metformin rescues cell surface major histocompatibility complex class I (MHC-I) deficiency caused by oncogenic transformation
    • Oliveras-Ferraros C, Cufi S, Vazquez-Martin A, Menendez OJ, Bosch-Barrera J, Martin-Castillo B, et al. Metformin rescues cell surface major histocompatibility complex class I (MHC-I) deficiency caused by oncogenic transformation. Cell Cycle 2012;11:865-70.
    • (2012) Cell Cycle , vol.11 , pp. 865-870
    • Oliveras-Ferraros, C.1    Cufi, S.2    Vazquez-Martin, A.3    Menendez, O.J.4    Bosch-Barrera, J.5    Martin-Castillo, B.6
  • 36
    • 59049104410 scopus 로고    scopus 로고
    • Effect of lapatinib on the development of estrogen receptor-negative mammary tumors in mice
    • Strecker TE, Shen Q, Zhang Y, Hill JL, Li Y, Wang C, et al. Effect of lapatinib on the development of estrogen receptor-negative mammary tumors in mice. J Natl Cancer Inst 2009;101:107-13.
    • (2009) J Natl Cancer Inst , vol.101 , pp. 107-113
    • Strecker, T.E.1    Shen, Q.2    Zhang, Y.3    Hill, J.L.4    Li, Y.5    Wang, C.6
  • 37
    • 0037103316 scopus 로고    scopus 로고
    • Immunomodulatory effects of RXR rexinoids: Modulation of high-affinity IL-2R expression enhances susceptibility to denileukin diftitox
    • DOI 10.1182/blood-2002-01-0300
    • Gorgun G, Foss F. Immunomodulatory effects of RXR rexinoids: modulation of high-affinity IL-2R expression enhances susceptibility to denileukin diftitox. Blood 2002;100:1399-403. (Pubitemid 34864297)
    • (2002) Blood , vol.100 , Issue.4 , pp. 1399-1403
    • Gorgun, G.1    Foss, F.2
  • 39
    • 0037236792 scopus 로고    scopus 로고
    • Anticancer potential of curcumin: Preclinical and clinical studies
    • Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003;23:363-98. (Pubitemid 36361976)
    • (2003) Anticancer Research , vol.23 , Issue.1 A , pp. 363-398
    • Aggarwal, B.B.1    Kumar, A.2    Bharti, A.C.3
  • 41
    • 0034113598 scopus 로고    scopus 로고
    • Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile
    • DOI 10.1006/jsre.2000.5826
    • Churchill M, Chadburn A, Bilinski RT, Bertagnolli MM. Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile. J Surg Res 2000;89:169-75. (Pubitemid 30196521)
    • (2000) Journal of Surgical Research , vol.89 , Issue.2 , pp. 169-175
    • Churchill, M.1    Chadburn, A.2    Bilinski, R.T.3    Bertagnolli, M.M.4
  • 45
    • 44449168711 scopus 로고    scopus 로고
    • Protective immunosurveillance and therapeutic antitumor activity of gammadelta T cells demonstrated in a mouse model of prostate cancer
    • Liu Z, Eltoum IE, Guo B, Beck BH, Cloud GA, Lopez RD. Protective immunosurveillance and therapeutic antitumor activity of gammadelta T cells demonstrated in a mouse model of prostate cancer. J Immunol 2008;180:6044-53.
    • (2008) J Immunol , vol.180 , pp. 6044-6053
    • Liu, Z.1    Eltoum, I.E.2    Guo, B.3    Beck, B.H.4    Cloud, G.A.5    Lopez, R.D.6
  • 46
    • 75149146646 scopus 로고    scopus 로고
    • Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantation
    • Couzi L, Levaillant Y, Jamai A, Pitard V, Lassalle R, Martin K, et al. Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantation. J Am Soc Nephrol 2010;21:181-8.
    • (2010) J Am Soc Nephrol , vol.21 , pp. 181-188
    • Couzi, L.1    Levaillant, Y.2    Jamai, A.3    Pitard, V.4    Lassalle, R.5    Martin, K.6
  • 47
    • 15544390511 scopus 로고    scopus 로고
    • Aromatase inhibitors for breast cancer prevention
    • DOI 10.1200/JCO.2005.11.027
    • Cuzick J. Aromatase inhibitors for breast cancer prevention. J Clin Oncol 2005;23:1636-43. (Pubitemid 46211418)
    • (2005) Journal of Clinical Oncology , vol.23 , Issue.8 , pp. 1636-1643
    • Cuzick, J.1
  • 48
    • 0037455013 scopus 로고    scopus 로고
    • Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells
    • DOI 10.1084/jem.20021500
    • Gober HJ, Kistowska M, Angman L, Jeno P, Mori L, De Libero G. Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells. J Exp Med 2003;197:163-8. (Pubitemid 36152311)
    • (2003) Journal of Experimental Medicine , vol.197 , Issue.2 , pp. 163-168
    • Gober, H.-J.1    Kistowska, M.2    Angman, L.3    Jeno, P.4    Mori, L.5    De Libero, G.6
  • 49
    • 75149174238 scopus 로고    scopus 로고
    • Ibadronate may prevent colorectal carcinogenesis in mice with ulcerative colitis
    • Sassa S, Okabe H, Nemoto N, Kikuchi H, Kudo H, Sakamoto S. Ibadronate may prevent colorectal carcinogenesis in mice with ulcerative colitis. Anticancer Res 2009;29:4615-9.
    • (2009) Anticancer Res , vol.29 , pp. 4615-4619
    • Sassa, S.1    Okabe, H.2    Nemoto, N.3    Kikuchi, H.4    Kudo, H.5    Sakamoto, S.6
  • 50
    • 77955870208 scopus 로고    scopus 로고
    • Use of bisphosphonates and risk of postmenopausal breast cancer
    • Rennert G, Pinchev M, Rennert HS. Use of bisphosphonates and risk of postmenopausal breast cancer. J Clin Oncol 2010;28:3577-81.
    • (2010) J Clin Oncol , vol.28 , pp. 3577-3581
    • Rennert, G.1    Pinchev, M.2    Rennert, H.S.3
  • 51
    • 79952757671 scopus 로고    scopus 로고
    • Use of bisphosphonates and reduced risk of colorectal cancer
    • Rennert G, Pinchev M, Rennert HS, Gruber SB. Use of bisphosphonates and reduced risk of colorectal cancer. J Clin Oncol 2011;29:1146-50.
    • (2011) J Clin Oncol , vol.29 , pp. 1146-1150
    • Rennert, G.1    Pinchev, M.2    Rennert, H.S.3    Gruber, S.B.4
  • 52
    • 79959916377 scopus 로고    scopus 로고
    • High phosphoantigen levels in bisphosphonate-treated human breast tumors promote Vgamma9Vdelta2 T-cell chemotaxis and cytotoxicity in vivo
    • Benzaid I, Monkkonen H, Stresing V, Bonnelye E, Green J, Monkkonen J, et al. High phosphoantigen levels in bisphosphonate-treated human breast tumors promote Vgamma9Vdelta2 T-cell chemotaxis and cytotoxicity in vivo. Cancer Res 2011;71:4562-72.
    • (2011) Cancer Res , vol.71 , pp. 4562-4572
    • Benzaid, I.1    Monkkonen, H.2    Stresing, V.3    Bonnelye, E.4    Green, J.5    Monkkonen, J.6
  • 53
    • 0034660687 scopus 로고    scopus 로고
    • Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma
    • Kunzmann V, Bauer E, Feurle J, Weissinger F, Tony HP, Wilhelm M. Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 2000;96:384-92. (Pubitemid 30463353)
    • (2000) Blood , vol.96 , Issue.2 , pp. 384-392
    • Kunzmann, V.1    Bauer, E.2    Feurle, J.3    Weissinger, F.4    Tony, H.-P.5    Wilhelm, M.6
  • 54
    • 0033522147 scopus 로고    scopus 로고
    • Gamma/delta T-cell stimulation by pamidronate
    • Kunzmann V, Bauer E, Wilhelm M. Gamma/delta T-cell stimulation by pamidronate. N Engl J Med 1999;340:737-8.
    • (1999) N Engl J Med , vol.340 , pp. 737-738
    • Kunzmann, V.1    Bauer, E.2    Wilhelm, M.3
  • 57
    • 34247586576 scopus 로고    scopus 로고
    • Zoledronic acid has direct antiproliferative and antimetastatic effect on pancreatic carcinoma cells and acts as an antigen for delta2 gamma/delta T cells
    • DOI 10.1097/CJI.0b013e31802bff16, PII 0000237120070500000002
    • Marten A, Lilienfeld-Toal M, Buchler MW, Schmidt J. Zoledronic acid has direct antiproliferative and antimetastatic effect on pancreatic carcinoma cells and acts as an antigen for delta2 gamma/delta T cells. J Immunother 2007;30:370-7. (Pubitemid 46684427)
    • (2007) Journal of Immunotherapy , vol.30 , Issue.4 , pp. 370-377
    • Marten, A.1    Lilienfeld-Toal, M.V.2    Buchler, M.W.3    Schmidt, J.4
  • 58
    • 77954652637 scopus 로고    scopus 로고
    • In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients
    • Meraviglia S, Eberl M, Vermijlen D, Todaro M, Buccheri S, Cicero G, et al. In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients. Clin Exp Immunol 2010;161:290-7.
    • (2010) Clin Exp Immunol , vol.161 , pp. 290-297
    • Meraviglia, S.1    Eberl, M.2    Vermijlen, D.3    Todaro, M.4    Buccheri, S.5    Cicero, G.6
  • 60
    • 78049243425 scopus 로고    scopus 로고
    • Conditional regulatory T-cell depletion releases adaptive immunity preventing carcinogenesis and suppressing established tumor growth
    • Teng MW, Ngiow SF, von Scheidt B, McLaughlin N, Sparwasser T, Smyth MJ. Conditional regulatory T-cell depletion releases adaptive immunity preventing carcinogenesis and suppressing established tumor growth. Cancer Res 2010;70:7800-9.
    • (2010) Cancer Res , vol.70 , pp. 7800-7809
    • Teng, M.W.1    Ngiow, S.F.2    Von Scheidt, B.3    McLaughlin, N.4    Sparwasser, T.5    Smyth, M.J.6
  • 61
    • 80052397157 scopus 로고    scopus 로고
    • COX-2 inhibition alters the phenotype of tumor-associated macrophages from M2 to M1 in ApcMin/+mouse polyps
    • Nakanishi Y, Nakatsuji M, Seno H, Ishizu S, Akitake-Kawano R, Kanda K, et al. COX-2 inhibition alters the phenotype of tumor-associated macrophages from M2 to M1 in ApcMin/+mouse polyps. Carcinogenesis 2011;32:1333-9.
    • (2011) Carcinogenesis , vol.32 , pp. 1333-1339
    • Nakanishi, Y.1    Nakatsuji, M.2    Seno, H.3    Ishizu, S.4    Akitake-Kawano, R.5    Kanda, K.6
  • 63
    • 33745311263 scopus 로고    scopus 로고
    • 2-dependent mechanism
    • Mahic M, Yaqub S, Johansson CC, Tasken K, Aandahl EM. FOXP3+CD4+CD25+ adaptive regulatory T cells express cyclooxy-genase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism. J Immunol 2006;177:246-54. (Pubitemid 43939136)
    • (2006) Journal of Immunology , vol.177 , Issue.1 , pp. 246-254
    • Mahic, M.1    Yaqub, S.2    Johansson, C.C.3    Tasken, K.4    Aandahl, E.M.5
  • 65
    • 67349182119 scopus 로고    scopus 로고
    • Immoderate inhibition of estrogen by anastrozole enhances the severity of experimental polyarthritis
    • Wang J, Zhang Q, Jin S, Feng M, Kang X, Zhao S, et al. Immoderate inhibition of estrogen by anastrozole enhances the severity of experimental polyarthritis. Exp Gerontol 2009;44:398-405.
    • (2009) Exp Gerontol , vol.44 , pp. 398-405
    • Wang, J.1    Zhang, Q.2    Jin, S.3    Feng, M.4    Kang, X.5    Zhao, S.6
  • 66
    • 61349201682 scopus 로고    scopus 로고
    • Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients
    • Generali D, Bates G, Berruti A, Brizzi MP, Campo L, Bonardi S, et al. Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients. Clin Cancer Res 2009;15:1046-51.
    • (2009) Clin Cancer Res , vol.15 , pp. 1046-1051
    • Generali, D.1    Bates, G.2    Berruti, A.3    Brizzi, M.P.4    Campo, L.5    Bonardi, S.6
  • 67
    • 65249138393 scopus 로고    scopus 로고
    • Myeloid-derived suppressor cells: Linking inflammation and cancer
    • Ostrand-Rosenberg S, Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 2009;182:4499-506.
    • (2009) J Immunol , vol.182 , pp. 4499-4506
    • Ostrand-Rosenberg, S.1    Sinha, P.2
  • 68
    • 63949088142 scopus 로고    scopus 로고
    • Adoptive transfer of HER2/neu-specific T cells expanded with alternating gamma chain cytokines mediate tumor regression when combined with the depletion of myeloid-derived suppressor cells
    • Morales JK, Kmieciak M, Graham L, Feldmesser M, Bear HD, Manjili MH. Adoptive transfer of HER2/neu-specific T cells expanded with alternating gamma chain cytokines mediate tumor regression when combined with the depletion of myeloid-derived suppressor cells. Cancer Immunol Immunother 2009;58:941-53.
    • (2009) Cancer Immunol Immunother , vol.58 , pp. 941-953
    • Morales, J.K.1    Kmieciak, M.2    Graham, L.3    Feldmesser, M.4    Bear, H.D.5    Manjili, M.H.6
  • 70
    • 34249300128 scopus 로고    scopus 로고
    • Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells
    • DOI 10.1158/0008-5472.CAN-06-4174
    • Sinha P, Clements VK, Fulton AM, Ostrand-Rosenberg S. Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. Cancer Res 2007;67:4507-13. (Pubitemid 46815102)
    • (2007) Cancer Research , vol.67 , Issue.9 , pp. 4507-4513
    • Sinha, P.1    Clements, V.K.2    Fulton, A.M.3    Ostrand-Rosenberg, S.4
  • 71
    • 81555228400 scopus 로고    scopus 로고
    • Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells
    • Obermajer N, Muthuswamy R, Lesnock J, Edwards RP, Kalinski P. Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells. Blood 2011;118:5498-505.
    • (2011) Blood , vol.118 , pp. 5498-5505
    • Obermajer, N.1    Muthuswamy, R.2    Lesnock, J.3    Edwards, R.P.4    Kalinski, P.5
  • 72
    • 84255170450 scopus 로고    scopus 로고
    • PGE (2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment
    • Obermajer N, Muthuswamy R, Odunsi K, Edwards RP, Kalinski P. PGE (2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment. Cancer Res 2011;71:7463-70.
    • (2011) Cancer Res , vol.71 , pp. 7463-7470
    • Obermajer, N.1    Muthuswamy, R.2    Odunsi, K.3    Edwards, R.P.4    Kalinski, P.5
  • 73
    • 33845997430 scopus 로고    scopus 로고
    • Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion
    • DOI 10.1016/j.intimp.2006.09.021, PII S1567576906002797
    • Talmadge JE, Hood KC, Zobel LC, Shafer LR, Coles M, Toth B. Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion. Int Immunopharmacol 2007;7:140-51. (Pubitemid 46043318)
    • (2007) International Immunopharmacology , vol.7 , Issue.2 , pp. 140-151
    • Talmadge, J.E.1    Hood, K.C.2    Zobel, L.C.3    Shafer, L.R.4    Coles, M.5    Toth, B.6
  • 76
    • 0022916262 scopus 로고
    • 13-cis-Retinoic acid in the treatment of oral leukoplakia
    • Hong WK, Endicott J, Itri LM, Doos W, Batsakis JG, Bell R, et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986;315:1501-5. (Pubitemid 17052146)
    • (1986) New England Journal of Medicine , vol.315 , Issue.24 , pp. 1501-1505
    • Hong, W.K.1    Endicott, J.2    Itri, L.M.3
  • 77
    • 58149332680 scopus 로고    scopus 로고
    • Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma
    • Kusmartsev S, Su Z, Heiser A, Dannull J, Eruslanov E, Kubler H, et al. Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma. Clin Cancer Res 2008;14:8270-8.
    • (2008) Clin Cancer Res , vol.14 , pp. 8270-8278
    • Kusmartsev, S.1    Su, Z.2    Heiser, A.3    Dannull, J.4    Eruslanov, E.5    Kubler, H.6
  • 79
    • 36348989162 scopus 로고    scopus 로고
    • Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells
    • DOI 10.1158/0008-5472.CAN-07-2593
    • Nefedova Y, Fishman M, Sherman S, Wang X, Beg AA, Gabrilovich DI. Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells. Cancer Res 2007;67:11021-8. (Pubitemid 350145932)
    • (2007) Cancer Research , vol.67 , Issue.22 , pp. 11021-11028
    • Nefedova, Y.1    Fishman, M.2    Sherman, S.3    Wang, X.4    Beg, A.A.5    Gabrilovich, D.I.6
  • 80
    • 58549103730 scopus 로고    scopus 로고
    • Combination of all-trans retinoic acid and a human papillomavirus therapeutic vaccine suppresses the number and function of immature myeloid cells and enhances antitumor immunity
    • Song X, Ye D, Liu B, Cui J, Zhao X, Yi L, et al. Combination of all-trans retinoic acid and a human papillomavirus therapeutic vaccine suppresses the number and function of immature myeloid cells and enhances antitumor immunity. Cancer Sci 2009;100:334-40.
    • (2009) Cancer Sci , vol.100 , pp. 334-340
    • Song, X.1    Ye, D.2    Liu, B.3    Cui, J.4    Zhao, X.5    Yi, L.6
  • 81
    • 79961181485 scopus 로고    scopus 로고
    • Retinoic acid as a vaccine adjuvant enhances CD8+ T cell response and mucosal protection from viral challenge
    • Tan X, Sande JL, Pufnock JS, Blattman JN, Greenberg PD. Retinoic acid as a vaccine adjuvant enhances CD8+ T cell response and mucosal protection from viral challenge. J Virol 2011;85:8316-27.
    • (2011) J Virol , vol.85 , pp. 8316-8327
    • Tan, X.1    Sande, J.L.2    Pufnock, J.S.3    Blattman, J.N.4    Greenberg, P.D.5
  • 82
    • 84863248624 scopus 로고    scopus 로고
    • Curcumin induces the differentiation of myeloid-derived suppressor cells and inhibits their interaction with cancer cells and related tumor growth
    • Tu SP, Jin H, Shi JD, Zhu LM, Suo Y, Lu G, et al. Curcumin induces the differentiation of myeloid-derived suppressor cells and inhibits their interaction with cancer cells and related tumor growth. Cancer Prev Res 2012;5:205-15.
    • (2012) Cancer Prev Res , vol.5 , pp. 205-215
    • Tu, S.P.1    Jin, H.2    Shi, J.D.3    Zhu, L.M.4    Suo, Y.5    Lu, G.6
  • 83
    • 67650097007 scopus 로고    scopus 로고
    • Mucin-depleted foci show strong activation of in flammatory markers in 1,2-dimethylhydrazine-induced carcinogenesis and are promoted by the inflammatory agent sodium dextran sulfate
    • Femia AP, Dolara P, Luceri C, Salvadori M, Caderni G. Mucin-depleted foci show strong activation of in flammatory markers in 1,2-dimethylhydrazine- induced carcinogenesis and are promoted by the inflammatory agent sodium dextran sulfate. Int J Cancer 2009;125:541-7.
    • (2009) Int J Cancer , vol.125 , pp. 541-547
    • Femia, A.P.1    Dolara, P.2    Luceri, C.3    Salvadori, M.4    Caderni, G.5
  • 84
    • 33749345198 scopus 로고    scopus 로고
    • 2 Pathway
    • DOI 10.1053/j.gastro.2006.07.014, PII S001650850601540X
    • Oshima H, Matsunaga A, Fujimura T, Tsukamoto T, Taketo MM, Oshima M. Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway. Gastroenterology 2006;131:1086-95. (Pubitemid 44498691)
    • (2006) Gastroenterology , vol.131 , Issue.4 , pp. 1086-1095
    • Oshima, H.1    Matsunaga, A.2    Fujimura, T.3    Tsukamoto, T.4    Taketo, M.M.5    Oshima, M.6
  • 85
    • 2342587509 scopus 로고    scopus 로고
    • Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice
    • DOI 10.1038/sj.emboj.7600170
    • Oshima H, Oshima M, Inaba K, Taketo MM. Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice. EMBO J 2004;23:1669-78. (Pubitemid 38579527)
    • (2004) EMBO Journal , vol.23 , Issue.7 , pp. 1669-1678
    • Oshima, H.1    Oshima, M.2    Inaba, K.3    Taketo, M.M.4
  • 86
    • 81155126053 scopus 로고    scopus 로고
    • Combined blockade of integrin-alpha4beta1 plus cytokines SDF-1alpha or IL-1beta potently inhibits tumor inflammation and growth
    • Schmid MC, Avraamides CJ, Foubert P, Shaked Y, Kang SW, Kerbel RS, et al. Combined blockade of integrin-alpha4beta1 plus cytokines SDF-1alpha or IL-1beta potently inhibits tumor inflammation and growth. Cancer Res 2011;71:6965-75.
    • (2011) Cancer Res , vol.71 , pp. 6965-6975
    • Schmid, M.C.1    Avraamides, C.J.2    Foubert, P.3    Shaked, Y.4    Kang, S.W.5    Kerbel, R.S.6
  • 87
    • 76049128364 scopus 로고    scopus 로고
    • Nuclear factor-kappaB and tumor-associated macrophages
    • Mancino A, Lawrence T. Nuclear factor-kappaB and tumor-associated macrophages. Clin Cancer Res 2010;16:784-9.
    • (2010) Clin Cancer Res , vol.16 , pp. 784-789
    • Mancino, A.1    Lawrence, T.2
  • 88
    • 31544441610 scopus 로고    scopus 로고
    • Distinct role of macrophages in different tumor microenvironments
    • DOI 10.1158/0008-5472.CAN-05-4005
    • Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006;66:605-12. (Pubitemid 43165918)
    • (2006) Cancer Research , vol.66 , Issue.2 , pp. 605-612
    • Lewis, C.E.1    Pollard, J.W.2
  • 89
    • 67650469499 scopus 로고    scopus 로고
    • Overexpression of human beta-defensin-3 in oral dysplasia: Potential role in macrophage trafficking
    • Kawsar HI, Weinberg A, Hirsch SA, Venizelos A, Howell S, Jiang B, et al. Overexpression of human beta-defensin-3 in oral dysplasia: potential role in macrophage trafficking. Oral Oncol 2009;45:696-702.
    • (2009) Oral Oncol , vol.45 , pp. 696-702
    • Kawsar, H.I.1    Weinberg, A.2    Hirsch, S.A.3    Venizelos, A.4    Howell, S.5    Jiang, B.6
  • 91
    • 59449104523 scopus 로고    scopus 로고
    • A selective cyclooxygenase-2 inhibitor prevents inflammation-related squamous cell carcinogenesis of the forestomach via duodenogastric reflux in rats
    • Oba M, Miwa K, Fujimura T, Harada S, Sasaki S, Oyama K, et al. A selective cyclooxygenase-2 inhibitor prevents inflammation-related squamous cell carcinogenesis of the forestomach via duodenogastric reflux in rats. Cancer 2009;115:454-64.
    • (2009) Cancer , vol.115 , pp. 454-464
    • Oba, M.1    Miwa, K.2    Fujimura, T.3    Harada, S.4    Sasaki, S.5    Oyama, K.6
  • 92
    • 80051480631 scopus 로고    scopus 로고
    • Selective PGE(2) suppression inhibits colon carcinogenesis and modifies local mucosal immunity
    • Nakanishi M, Menoret A, Tanaka T, Miyamoto S, Montrose DC, Vella AT, et al. Selective PGE(2) suppression inhibits colon carcinogenesis and modifies local mucosal immunity. Cancer Prev Res 2011;4:1198-208.
    • (2011) Cancer Prev Res , vol.4 , pp. 1198-1208
    • Nakanishi, M.1    Menoret, A.2    Tanaka, T.3    Miyamoto, S.4    Montrose, D.C.5    Vella, A.T.6
  • 93
    • 80054075147 scopus 로고    scopus 로고
    • Tumour macrophages as potential targets of bisphosphonates
    • Rogers TL, Holen I. Tumour macrophages as potential targets of bisphosphonates. J Transl Med 2011;9:177.
    • (2011) J Transl Med , vol.9 , pp. 177
    • Rogers, T.L.1    Holen, I.2
  • 94
    • 78650051896 scopus 로고    scopus 로고
    • Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway
    • Coscia M, Quaglino E, Iezzi M, Curcio C, Pantaleoni F, Riganti C, et al. Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway. J Cell Mol Med 2010;14:2803-15.
    • (2010) J Cell Mol Med , vol.14 , pp. 2803-2815
    • Coscia, M.1    Quaglino, E.2    Iezzi, M.3    Curcio, C.4    Pantaleoni, F.5    Riganti, C.6
  • 95
    • 4944239035 scopus 로고    scopus 로고
    • An amino-bisphosphonate targets MMP-9 - Expressing macrophages and angiogenesis to impair cervical carcinogenesis
    • DOI 10.1172/JCI200422087
    • Giraudo E, Inoue M, Hanahan D. An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J Clin Invest 2004;114:623-33. (Pubitemid 39578752)
    • (2004) Journal of Clinical Investigation , vol.114 , Issue.5 , pp. 623-633
    • Giraudo, E.1    Inoue, M.2    Hanahan, D.3
  • 96
    • 79952284127 scopus 로고    scopus 로고
    • Hallmarks of cancer: The next generation
    • Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74.
    • (2011) Cell , vol.144 , pp. 646-674
    • Hanahan, D.1    Weinberg, R.A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.